missing translation for 'onlineSavingsMsg'
Learn More

Thermo Scientific™ Fluorescein-D22 Coactivator Peptide, 100 μM

LanthaScreen™ fluorescent nuclear receptor coregulator peptides contain known interaction motifs and are labeled with fluorescein. These peptides are matched and validated to complement the LanthaScreen™ TR-FRET Nuclear Receptor Coregulator Assays.

Marke:  Thermo Scientific™ PV4387

Weitere Details : Netto-Gewicht : 0.50000kg

 Weitere Artikel aus diesem Sortiment

Artikelnummer. 10036842

  • 978.00 € / 1 Milliliter
Verfügbar ab: 28-08-2024
Sie sich ein, um den Lagerbestand zu sehen

Nur für Forschungszwecke. Die Anwendung muss den Produktanweisungen entsprechen.


Beschreibung

Beschreibung

LanthaScreen™ fluorescent nuclear receptor coregulator peptides contain known interaction motifs and are labeled with fluorescein. These peptides are matched and validated to complement the LanthaScreen™ TR-FRET Nuclear Receptor Coregulator Assays. Assays developed using these reagents enable primary or secondary screening of nuclear receptor agonists and/or antagonists.

How they work

Ligand binding to nuclear receptors causes conformational changes in the receptor, resulting in a cascade of events, including dissociation of repressor proteins, association of coactivator proteins, and assembly of pol II and other transcriptional factors for activation of target genes. TR-FRET based assays can be developed using the LanthaScreen™ panel of fluorescein-labeled coregulator peptides to investigate conformational changes of nuclear receptors upon ligand binding, either by determining the affinity of ligand-bound receptor for different coregulator peptides, or by identifying additional agonists or antagonists via displacement or recruitment of a specific coregulator peptide. In the LanthaScreen™ TR-FRET RXR beta Coactivator Assay, a terbium (Tb)-labeled anti-GST antibody is used to indirectly label GSTtagged RXR beta protein. An agonist (9-cis Retinoic Acid) added to the receptor which, upon ligand binding, causes a conformational change resulting in recruitment of the Fl-D22 coactivator peptide (Figure 1). The binding of the fluorescent coregulator peptide to RXR beta causes an increase in the TR-FRET emission ratio (Figure 2).

Spezifikation

Spezifikation

≥ 95% Reinheit, bestimmt durch HPLC
100μ m
Fluorescein-D22Koaktivator-Peptid, 1 ml, Konzentration 100 μM, Molekulargewicht 2499 Da, Lagerungsbedingung -5 bis -30 °C, für Pharma und Biopharma, Target- und Bleiidentifizierung und -validierung
Klassische Farbstoffe
Fluorescein – D22 Koaktivator-Peptid
Nur für Forschungszwecke Darf nicht für diagnostische Verfahren eingesetzt werden.
Trockeneis
Fluorescein – D22 Koaktivator-Peptid
Lagern Sie die Peptide bei -20 °C.
Pharma und Biopharma, Ziel- und Lead-Erkennung und -Validierung, Arzneimittelforschung und -entwicklung, Biologie der Kernrezeptoren, Kernrezeptorproteine, biochemische Kernrezeptor-Assays, Kernrezeptor-Koregulatorinteraktion
2499 Da
1 ml
Fluorescein- LPYEGSLLLKLRAPVEEV
10 Mm Na2CO3 (pH 11.0)
Produktvorschläge

Produktvorschläge

Videos
Sicherheitsdatenblatt (SDS)
Dokumentation

Dokumentation

Zertifikate
Sonderangebote

Sonderangebote

For Research Use Only. Not for use in diagnostic procedures.